Andrew Evens, D.O.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew Evens, D.O. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00100711 · Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPharmacyclics LLC. · terminated · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 47 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Stem cell self-renewal in the mouse germlineF32HD052413 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2006 to 2008 · $51,278 awarded in 2008Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:20 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601).Cancer Chemother Pharmacol · 201270 citationsRCR 2.1
- Efficacy and safety of porous hydroxyapatite/type 1 collagen composite implantation for bone regeneration: A randomized controlled study.J Orthop Sci · 201661 citationsRCR 3.3
- The effect of succinylated atelocollagen and ablative fractional resurfacing laser on striae distensae.J Dermatolog Treat · 201126 citationsRCR 1.5
- Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.Int J Cancer · 202120 citationsRCR 1.3
- 13 citationsRCR 3.7
- Effects of an inclined board as a training tool on the take-off motion of the long jump.Sports Biomech · 20054 citationsRCR 0.2